These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 10651186

  • 1. Negative chronotropic and inotropic effects of class I antiarrhythmic drugs assessed in isolated canine blood-perfused sinoatrial node and papillary muscle preparations.
    Sugiyama A, Takehana S, Kimura R, Hashimoto K.
    Heart Vessels; 1999; 14(2):96-103. PubMed ID: 10651186
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular effects of optical isomers of cibenzoline, assessed in the canine isolated, blood-perfused papillary muscle and sinoatrial node preparations.
    Takehana S, Sugiyama A, Hashimoto K.
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):660-5. PubMed ID: 10547081
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of the action of antiarrhythmic drugs on sinoatrial nodal pacemaker activity and contractility in the isolated blood-perfused atrium of the dog.
    Chiba S.
    Clin Exp Pharmacol Physiol; 1976 Nov; 3(6):599-608. PubMed ID: 1009695
    [Abstract] [Full Text] [Related]

  • 4. Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade.
    Honerjäger P, Loibl E, Steidl I, Schönsteiner G, Ulm K.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):184-95. PubMed ID: 2422563
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of cardiovascular effects of a novel class Ic antiarrhythmic agent, NIK-244, with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog.
    Sugiyama A, Motomura S, Hashimoto K.
    Jpn J Pharmacol; 1991 May; 56(1):1-12. PubMed ID: 1908917
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs.
    Sugiyama A, Motomura S, Hashimoto K.
    Jpn J Pharmacol; 1994 Nov; 66(3):303-16. PubMed ID: 7869617
    [Abstract] [Full Text] [Related]

  • 9. Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
    Shimotori M, Kobayashi M, Chiba S.
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):67-79. PubMed ID: 6721625
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K, Ishii M, Komori S, Mitsuhashi H.
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG, Hatley FR, McDonald SJ, Stamm MH, Garthwaite SM.
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [Abstract] [Full Text] [Related]

  • 14. Relationship between negative inotropic and chronotropic effects of tocainide and five class I antiarrhythmic drugs in the coronary perfused guinea-pig heart.
    Matsumoto T, Hasegawa J, Mashiba H.
    Gen Pharmacol; 1993 May; 24(3):599-604. PubMed ID: 8365639
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular effects of a new phenoxyalkylamine derivative, 2-isopropyl-5-[3-(2-methoxyphenoxy)propylamino]-2-(3,4,5-trimethoxy phenyl) valeronitrile fumarate (HV-525), in cross-circulated dog atrial preparations.
    Chiba S, Ogiwara Y, Furukawa Y, Saegusa K.
    Jpn Heart J; 1987 Mar; 28(2):261-72. PubMed ID: 3599413
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y, Kawada M, Sawanobori K, Sonoki H, Inoue K, Mizuno K, Itou T, Tabunoki Y, Tsukamoto M, Ohashi Y, Kyotani Y, Shimizu N, Fujii M, Nakamura M.
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles.
    Kawamura T, Kodama I, Toyama J, Hayashi H, Saito H, Yamada K.
    Cardiovasc Res; 1990 Nov; 24(11):925-31. PubMed ID: 2176934
    [Abstract] [Full Text] [Related]

  • 20. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
    Wu B, Sato T, Kiyosue T, Arita M.
    Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.